Wellington Management Group
JUNO

Wellington Management Group’s Juno Therapeutics, Inc. JUNO Stock Holding History

Wellington Management Group’s Portfolio JUNO Stock Details JUNO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q2 		– Sell
-1,007,324
Closed -$61.1M – 2275
2015
Q1 		$61.1M Sell
1,007,324
-142,760
-12% -$6.93M 0.02% 671
2014
Q4 		$58.9M Buy
+1,150,084
New +$51.5M 0.02% 684

Other funds holding JUNO

CM
Crestline Management Fort Worth, Texas $46.3M AUM 48.82% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
OFM
Omega Fund Management Boston, Massachusetts $163M AUM 107.06% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return
Lord, Abbett & Co
Lord, Abbett & Co Jersey City, New Jersey $30.6B AUM 57.44% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
BB
BB Biotech Schaffhausen, Switzerland $3.98B AUM 15.47% 1-Year Est. Return

Wellington Management Group's JUNO Position: Q2 2015 in Review

Wellington Management Group sold out of Juno Therapeutics, Inc. (JUNO) in Q2 2015, closing a stake of 1,007,324 shares — an estimated $61.1M sold.

Wellington Management Group first reported a position in JUNO in Q4 2014 and held it in 2 quarters. The position peaked at $61.1M in Q1 2015. 154 funds tracked by Wall St. Rank hold JUNO as of Q2 2015.

  • Wellington Management Group reported no remaining Juno Therapeutics, Inc. position as of Q2 2015 after selling out during the quarter.
  • Wellington Management Group sold 1,007,324 Juno Therapeutics, Inc. shares in Q2 2015, an estimated $61.1M.
  • Wellington Management Group first reported a position in Juno Therapeutics, Inc. in Q4 2014 and held it in 2 quarters.
  • Wellington Management Group's Juno Therapeutics, Inc. position peaked at $61.1M in Q1 2015.
  • 154 funds tracked by Wall St. Rank held Juno Therapeutics, Inc. as of Q2 2015.

Based on Wellington Management Group's 13F filing for Q2 2015, filed 14 Aug 2015.